MedPath

葵花药业集团(冀州)有限公司

Ownership
-
Established
2001-04-27
Employees
-
Market Cap
-
Website
www.kuihuayaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

44

NMPA:44

Drug Approvals

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20093039
Approval Date
Apr 19, 2023
NMPA

热毒平颗粒

Approval Number
国药准字Z20064128
Approval Date
Apr 8, 2021
NMPA

Marine Injection

Product Name
苦参素注射液
Approval Number
国药准字H20058410
Approval Date
Nov 6, 2020
NMPA

Compound Aminophenazone and Barbital Injection

Product Name
复方氨林巴比妥注射液
Approval Number
国药准字H20057895
Approval Date
Nov 6, 2020
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20057902
Approval Date
Nov 3, 2020
NMPA

Gentamicin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H20057898
Approval Date
Nov 3, 2020
NMPA

Lomefloxacin Aspartate Injection

Product Name
门冬氨酸洛美沙星注射液
Approval Number
国药准字H20058222
Approval Date
Nov 3, 2020
NMPA

Gentamicin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H13021395
Approval Date
Nov 3, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20057896
Approval Date
Nov 3, 2020
NMPA

Gentamicin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H20057897
Approval Date
Nov 3, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.